Study: Cannabinoids May Reduce Inflammation Caused by Mycobacterium

Marijuana_Plants-3Mycobacterium is a genus of Actinobacteria that is known to cause diseases such as tuberculosis and leprosy. According to a new study published in the July issue of the journal Inflammation Research, and e-published ahead of print by the National Institute of Health, cannabinoids may reduce inflammation caused by the bacteria.

For the study, researchers investigated the anti-inflammatory effect of two cannabinoid receptor agonists (meant to mimic the effects of cannabinoids) “in inflammatory experimental model induced by Mycobacterium bovis (BCG).” Mice pretreated with the agonists were induced with “pleurisy or pulmonary inflammation”.

Read moreStudy: Cannabinoids May Reduce Inflammation Caused by Mycobacterium

New Study: Cannabis May Treat Autoimmune Diseases, Prevent Graft Rejection

A newflower study being published in the upcoming issue of the Journal of Neuroimmune Pharmacology, and e-published ahead of print by the National Institute of Health, has found that cannabis may have immunosuppressive and anti-inflammatory properties, which may help treat a variety of conditions such as autoimmune diseases and graft rejection.

According to researchers; “This review examines the effects of cannabinoids on immune function, with a focus on effects on T-cells, as well as on resistance to infection. The paper considers the immune modulating capacity of marijuana, of ∆9-THC extracted from the marijuana plant, and synthetic cannabinoids.”

Read moreNew Study: Cannabis May Treat Autoimmune Diseases, Prevent Graft Rejection